← All posts
Guide20 Nov 20268 min read

What is an FDA warning letter? A plain-English guide

What an FDA warning letter is, what usually comes before one, what the company has to do in the next 15 working days, and what happens if the response falls short. With real 2026 examples.

FDA Brief team

An FDA warning letter is a formal notice that FDA believes a company has broken the Federal Food, Drug, and Cosmetic Act or one of its regulations, and that the problem is serious enough to need a fix. It is not a fine and it is not a court order. It is FDA putting the company on notice, in writing and in public, that more serious action can follow if nothing changes.

That public part matters. FDA posts warning letters on fda.gov, so customers, competitors, investors and journalists can read them too.

How a company usually ends up with one

Most warning letters follow the same path.

  1. An inspection or a review. An FDA investigator inspects a plant, or FDA reviews a website, product labels, import records or samples. Many recent letters to online sellers came from website reviews with no inspection at all.
  2. A Form FDA 483. At the end of an inspection the investigator hands over a list of observations, the Form 483. It is the investigator's list, not yet an agency decision.
  3. The company responds. Firms are expected to answer the 483 in writing, usually within 15 business days. This is the best chance to avoid a warning letter.
  4. FDA reviews and decides. If FDA finds the violations significant and the response weak or unsupported, it issues a warning letter. Letters often quote the company's own response and explain why it was not enough.

That review takes time. In our database, many letters issued in late 2026 describe inspections from late 2025 or early 2026.

What is in a warning letter

Every letter has roughly the same parts:

  • Who and where: the company, the facility address and often the person it is addressed to.
  • What FDA looked at: the inspection dates, or the website or records it reviewed.
  • The violations: each one with the regulation it breaks, for example 21 CFR 211.192 for failing to investigate a failed batch, or 21 CFR 1.502(a) for an importer with no Foreign Supplier Verification Program.
  • What FDA thinks of the response: often point by point.
  • What FDA wants now: a written reply within 15 working days that says what the company is fixing, with documents to show it.
  • The consequences: what FDA may do next if the problems are not corrected.

Real examples from 2026

A few letters posted in the last month show the range:

  • LGM Pharma Solutions, a tablet maker in Irvine, California, was cited for weak investigations of out-of-specification assay results and for approving process validation after a batch failed. One commercial batch had already been recalled.
  • CNC Noodle Corporation in Hayward, California, had no preventive controls for Bacillus cereus, Clostridium botulinum or undeclared wheat, and condensate was dripping onto exposed noodles.
  • Next Medical Products, an ultrasound gel maker in New Jersey, shipped gel contaminated with bacteria and never filed the required report after telling customers to discard it.
  • Safi Pushcart Supplies, a New York food importer, had no supplier verification program at all for the rice and oil it imported.

How many FDA sends

FDA Brief tracks every warning letter FDA has posted since January 2021, over 3,800 so far. Counts by year of issue:

YearLetters
2021654
2022683
2023612
2024567
2025742
2026 (to mid November)561

Over the last 12 months, drugs led by a wide margin:

AreaLetters, last 12 months
Drugs320
Food149
Tobacco78
Devices53
Biologics24
Animal products21

The gap between issued and posted

A letter is dated when FDA sends it, but it shows up on fda.gov later. Across 646 letters from the last 12 months, the median gap was 12 days, and a quarter took more than a month. It varies by area: about 11 days for drug letters, 26 for devices and 35 for food.

So by the time most people read a letter, the company's 15 working day clock is already half gone or over. If one of your suppliers gets a letter, that is your cue to ask what they sent FDA, not to wait and see.

What happens after the letter

The company replies, often more than once, and FDA reviews the fixes, sometimes with another inspection. When FDA is satisfied, it can send a close-out letter, which also gets posted.

If the problems continue, FDA can escalate. Depending on the product, that can mean:

  • Import alerts, which let FDA detain a foreign firm's shipments at the border without examining them.
  • Holding up approvals, so pending drug applications from that site may not be approved.
  • Refusing export certificates.
  • Seizure of product, or an injunction, which often ends in a consent decree: a court order with strict terms on how the company must operate.

Warning letter vs untitled letter vs Form 483

Form 483Untitled letterWarning letter
Who issues itThe investigator, at the end of an inspectionFDAFDA
SeriousnessObservations, not a final findingViolations that do not meet the warning letter barSignificant violations
Response expectedYes, usually within 15 business daysOftenYes, within 15 working days
Threatens enforcementNoNoYes
Posted publiclyNot routinelySome areYes

Keeping up without reading every letter

FDA posts letters in weekly batches across every product area. If you only care about a few suppliers, a product type or a topic like sterility failures, reading them all is not a good use of a week.

FDA Brief reads every new warning letter and recall and emails you the ones that match your watches: company names (with loose matching for subsidiaries and name variants), words anywhere in the letter text, or a short description of what you care about. Each letter gets a plain-English summary like the ones above, with the violations, the regulation cited and what FDA asked for. The free plan covers three watches.